Stock Events

Stock Events

Spyre Therapeutics (3920.F) Q2 2026 Earnings

7MayConfirmed

Q3 2025

Q4 2025

Q1 2026

Next

-0.66

-0.49

-0.31

-0.13

Details

Expected EPS

-0.5688813023400001

Actual EPS

N/A

Surprise EPS

0.57

Surprise Percent

+100%

Description

Spyre Therapeutics (3920.F) will report earnings of for Q2 2026 on May 07, 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.